Phase 4
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Male
Prostatic Neoplasms, Adenocarcinoma
Male
Prostatic Neoplasms, Adenocarcinoma
Trial Information
Inclusion Criteria:
- Biopsy proven adenocarcinoma of the prostate
- Deemed a surgical candidate for a bilateral nerve bundle preservation
- Potent
- Continent of urine
- Surgical candidate for both open and robotic nerve-sparing radical prostatectomy
- Age >18
Exclusion Criteria:
- Previous treatment of prostate cancer (radiation, hormones, etc.)
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Trifecta
Outcome Description:
Free from biochemical recurrence, continent, and potent 2 years after radical prostatectomy
Outcome Time Frame:
at 2 years
Safety Issue:
No
Authority:
United States: Institutional Review Board
Study ID:
IRB# 11-002288
NCT ID:
NCT01365143
Start Date:
May 2011
Completion Date:
May 2016
Related Keywords:
- Prostatic Neoplasms
- Adenocarcinoma
- Adenocarcinoma
- Adenocarcinoma, Mucinous
- Neoplasms
- Prostatic Neoplasms
Name | Location |
|---|---|
| Mayo Clinic | Rochester, Minnesota 55905 |
